Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA Predicting Postoperative Recurrence and Progression After Systemic Therapy of Hepatocellular Carcinoma

NCT06178809 is registered in ClinicalTrials.gov with Singlera Genomics Inc. as lead sponsor.

NCT NCT06178809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06178809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA Predicting Postoperative Recurrence and Progression After Systemic Therapy of Hepatocellular Carcinoma
Lead sponsor
Singlera Genomics Inc.
Phase
Observational
Overall status
Unknown status
Start date
December 25, 2023
Completion date
December 31, 2025
Enrollment
475 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma